Horror Report

Tag: vaccine

  • Covid booster Friday night safety news dump

    Covid booster Friday night safety news dump

    The US Centers for Disease Control and Prevention said Friday that there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech..

    The CDC said one of its vaccine safety monitoring systems – a “near real-time surveillance system” called the Vaccine Safety Datalink – detected a possible increase in a certain kind of stroke in people 65 and older who recently got one of Pfizer’s updated booster shots.

    “A rapid response analysis” of that signal revealed that seniors who got an bivalent booster might be more likely to have ischemic strokes within the first three weeks after their shots, compared with weeks four through six.

    Ischemic strokes, the most common form, are blockages of blood to the brain.

    They’re usually caused by clots..

    Officials continue to say that people should be vaccinated and boosted against Covid-19, while media outlets largely downplay any safety issues regarding the vaccine..

    Developing..

  • Fourth woman dead from rare clots after Johnson and Johnson vaccine administered

    Fourth woman dead from rare clots after Johnson and Johnson vaccine administered

    A woman in her late 30s has died of a rare blood clotting condition nearly two weeks after receiving a single-dose Johnson & Johnson COVID-19 vaccine in Washington, according to state health officials. The woman is the first confirmed death in King County, and the fourth person to die nationwide out of the nearly 15 million people who have received the J&J shot since it became available in the U.S.

    “We at Public Health are saddened by this loss and offer condolences to the woman’s family and loved ones,” the county’s public health department said in a statement released Tuesday. “As with many medications, the risk of serious adverse events is small, but not zero. It is vital for people to have this information in order to make their own informed decisions.”

    The news release indicates that she received her vaccine in late August and died some two weeks later, right around the same mark that previous deaths had occurred from this rare disorder.

    Read more at: https://www.thenewstribune.com/news/coronavirus/article254781422.html#storylink=cpy

  • Pfizer set to submit to FDA: Covid vaccine ‘safe’ in kids

    Pfizer set to submit to FDA: Covid vaccine ‘safe’ in kids

    Pfizer and BioNTech’s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of kids ages 5 to 11, the drugmakers announced Monday.

    The companies tested a two-dose regimen of 10 micrograms — about a third the dosage used for teens and adults — administered three weeks apart. They said the shots were well tolerated and produced an immune response and side effects comparable to those seen in a study of people ages 16 to 25

  • VACCINE 3: JOHNSON & JOHNSON EMERGENCY USE AUTHORIZED

    VACCINE 3: JOHNSON & JOHNSON EMERGENCY USE AUTHORIZED

    • The FDA has authorized third vaccine with Johnson & Johnson one-shot jab to be distributed as early as Monday 
    • By the end of March, J&J has said it expects to deliver 20 million doses to the U.S., and 100 million by summer 
    • Worldwide, company aims to produce 1 billion doses globally by the end of 2021 
    • Johnson & Johnson shot only requires a single shot compared to Pfizer and Moderna’s jabs 

    VARIOUS MEDIA REPORTING..

    The vaccine, made by Janssen, J&J’s vaccine arm, is safe and effective, and it’s considered flexible. It’s a single dose, and it doesn’t require special storage.

    The vaccine is authorized for people ages 18 and older.

    New Jersey-based Johnson & Johnson said 20 million doses would be delivered in the US by the end of March. The company plans to deliver 100 million doses during the first half of 2021.

    The doses can be stored in a standard fridge, unlike the ultra-cold conditions required by the other two vaccines from Moderna and Pfizer/BioNTech, both of which are two-shot regimes.

    “We need a vaccine that can be quickly mass produced,” Dr. Greg Poland, head of the Mayo Clinic’s Vaccine Research Group, said Friday. “We’d want to see a reasonable duration of efficacy and protection.

    Developing..

  • COVID-19.. AND 20.. AND 21.. AND 22

    COVID-19.. AND 20.. AND 21.. AND 22

    Johnson & Johnson CEO Alex Gorsky told CNBC on Tuesday that annual COVID shots may be necessary…

    While some have pondered few have spoken about the need for regular COVID vaccines..

    “Unfortunately, as [the virus] spreads it can also mutate,” he told CNBC’s Meg Tirrell during a Healthy Returns Spotlight event. “Every time it mutates, it’s almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend off antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine.”

    X X X

    Meanwhile, other vaccine related news is making rounds.. there are fears that some who received the Moderna shot have developed a rare blood disorder. While more investigation and medical research is necessary, the New York TIMES article about the possibility have caused alarm.. Denise Grady writes of the fear, but the battle against bad data:

    More than 31 million people in the United States have received at least one dose, and 36 similar cases had been reported to the government’s Vaccine Adverse Event Reporting System, VAERS, by the end of January. The cases involved either the Pfizer-BioNTech or Moderna vaccine, the only two authorized so far for emergency use in the United States. But the reporting system shows only problems described by health care providers or patients after vaccination, and does not indicate whether the shots actually caused the problems.

    The AP report on a poll from The Associated Press-NORC Center for Public Affairs Research. It found that while 67% of Americans plan to get vaccinated or have already done so, 15% are certain they won’t and 17% say probably not. Many expressed doubts about the vaccine’s safety and effectiveness..

    X X X

    Finally, there is news on the long haulers–those who have had COVID but cannot shake long term problems since diagnosis.. POST-COVID brain: Problems remembering names and conversations, difficulty paying attention, and slower processing speeds — these are all symptoms that people are experiencing post-COVID-19 infections..

    Finally, if you want to try staying beautiful for a future in which society (maybe) will open again, “Maskne” is your latest fear. Doctors are reporting an increase in acne around the face mask area on people who never experienced it before..

  • The varying varients

    The varying varients

    New fears over the variants!

    Oxford/AstraZeneca COVID-19 shot less effective against South African variant

    AP: 

    British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.

    The study from South Africa’s University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variant, according to a Financial Times report published earlier in the day.

    Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants, which appear to spread more swiftly than others.

    “In this small phase I/II trial, early data has shown limited efficacy against mild disease primarily due to the B.1.351 South African variant,” an AstraZeneca spokesman said in response to the FT report.

    The newspaper said none of the more than 2,000 trial participants had been hospitalized or died.

    Just days ago, it was reported that more than 4,000 variants are making their way around the planet ..  

    “Its very unlikley that the current vaccine won’t be effective on the variants whether in Kent or other variants especially when it comes to severe illness and hospitalization,” Vaccine Deployment Minister Nadhim Zahawi told Sky News in the UK..

    “All manufacturers, Pfizer-Biontech, Moderna, Oxford-AstraZeneca and others are looking at how they can improve their vaccine to make sure that we are ready for any variant – there are about 4,000 variants around the world of COVID now.”

  • California pauses Moderna vaccine at one location after allergic reactions

    California pauses Moderna vaccine at one location after allergic reactions

    MORE..

    After several people had apparent allergic reactions at one California clinic, state health officials on Sunday told providers across the state to pause administering doses from one COVID-19 vaccine lot that arrived from Moderna.

    The move, made “out of an extreme abundance of caution,” means that 330,000 doses distributed to 287 providers across the state can’t be used amid an already slow vaccine rollout.

    “A higher-than-usual number of possible allergic reactions were reported with a specific lot of Moderna vaccine administered at one community vaccination clinic,” California State Epidemiologist Dr. Erica Pan said.

  • ILLINOIS MEDICAL CENTER PAUSES PFIZER VACCINES AFTER REACTIONS REPORTED

    ILLINOIS MEDICAL CENTER PAUSES PFIZER VACCINES AFTER REACTIONS REPORTED

    ABC NEWS reports that four workers had elevated heart rates and “tingling” ..

    MORE..

    Officials are stating it is a normal side effect..

    MORE:

    Advocate Aurora Health, a health care system in Wisconsin and Illinois, said Friday that it paused COVID-19 vaccinations after health care workers “experienced reactions” from the Pfizer shot. Four team members at Advocate Condell Medical Center in Libertyville, Illinois, experienced “tingling and elevated heart rate,” according to a press release. The center’s vaccination program is temporarily paused as experts investigate.”These four team members represent fewer than 0.15% of the approximately 3,000 who have so far received vaccinations across Advocate Aurora Health. At this time, we can share three team members are home and doing well, and one is receiving additional treatment,” Advocate Aurora Health said in a statement. They explained that reactions are an expected side effect of vaccination, and they still encourage others to get vaccinated to put an end to the coronavirus pandemic.

  • Flash: AstraZeneca will conduct new global vaccine trial after error!

    Flash: AstraZeneca will conduct new global vaccine trial after error!

    AstraZeneca said it plans to conduct a new global clinical trial to assess the Oxford-AstraZeneca vaccine’s efficacy. The news comes after the company and the university acknowledged a dosing error in trials.

    More: In a statement Wednesday, Oxford University said some of the vials used in the trial didn’t have the right concentration of vaccine so some volunteers got a half dose. The university said that it discussed the problem with regulators, and agreed to complete the late-stage trial with two groups.

    The manufacturing problem has been corrected, according to the statement.

  • Vaccine test paused at Johnson and Johnson

    Vaccine test paused at Johnson and Johnson

    The company released a statement on Monday, saying “We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 Ensemble trial, due to an unexplained illness in a study participant.”

    The vaccine was being tested in 60,000 participants across the US, Argentina, Brazil and several other countries.

    In September, pharmaceutical company AstraZeneca paused clinical trials of an experimental COVID-19 vaccine after a participant in the UK had an unexplained illness, but the study has since resumed in the country.

    DEVELOPING..